Jul 07, 2023
With the anticipated launch of emerging therapies, the liver cirrhosis treatment market is poised to undergo a significant transformation.
Read More...
Jun 26, 2023
The uveitis treatment market is evolving in the coming years with newer drugs and innovative advances in ocular drug delivery.
Read More...
Jun 23, 2023
The GvHD treatment market is anticipated to grow significantly in the coming years as several companies are developing novel therapies.
Read More...
May 05, 2023
Despite many clinically failed attempts, GSK finally set to launch RSVPreF3, the first preventive respiratory syncytial virus vaccine.
Read More...
Apr 26, 2023
Physiotherapy, also called physical therapy, is critical in providing holistic treatment for various disorders, injuries, and diseases. It improves mobility, strength, balance, and coordination. Especially in the case of injury, or chronic pain, it can have a long-lasting impact and greatly help manage the symptoms...
Read More...
Apr 24, 2023
Bronchiectasis is a chronic respiratory condition where the bronchial tubes in the lungs become damaged, inflamed, and widened, leading to a buildup of mucus that makes breathing difficult. The condition can develop for various reasons, including infections, genetic disorders, autoimmune conditions, and other facto...
Read More...
Apr 21, 2023
To address challenges, pharma giants GSK & Pfizer are bringing first vaccine for respiratory syncytial virus treatment to adult population.
Read More...
Apr 19, 2023
The Body Contouring Devices market is evolving at an immense pace due to the ongoing trends and developments in the domain. Companies are developing new products
Read More...
Apr 14, 2023
Vertex & CRISPR Therapeutics become first companies to submit marketing application for CRISPR gene-editing therapy exa-cel for SCD & TDT.
Read More...
Apr 14, 2023
DelveInsight has analyzed some of the key abstracts and top data readouts from the American Association for Cancer Research (AACR) 2023. Several pharma and biotech companies
Read More...
Roche’s HER2-Positive Breast Cancer Treatment Franchise
Aug 13, 2024
Transforming Multiple Myeloma Treatment: The Promise of Novel Drug Classes
Jul 24, 2024
Newsletter/Whitepaper